These grants provide up to £30,000 over 1-2 years for research costs, to support Clinical Lecturers who are looking to develop and strengthen their research careers.
Round 30 is closed to applications.
These grants provide up to £30,000 over 1-2 years for research costs, to support Clinical Lecturers who are looking to develop and strengthen their research careers.
Round 30 is closed to applications.
The above diagram illustrates the application process for the two rounds of the Starter Grants award and provides rough dates for each stage. Please note that these dates are to serve as a guide only and can be subject to change .
About the scheme
This scheme was launched in October 2008 as a partnership between the Academy and the Wellcome Trust. Current funders of the scheme are the Wellcome Trust, British Heart Foundation (since 2011), Versus Arthritis (since 2012), Medical Research Council (since 2013), Diabetes UK (since 2016), the Association of Physicians of Great Britain & Ireland (since 2020) and Prostate Cancer UK (since 2023). We recently celebrated ten years since the launch of the Starter Grants for Clinical Lecturers scheme. The achievements of the awardees are cause for celebration. To mark this, we have published our ‘Starter for 10: a decade of supporting academic Clinical Lecturers’ report which sets out the successes and includes case studies drawn from the last decade.
The grants provide modest ‘starter’ funds to enable research active Clinical Lecturers to pursue their research work. Clinical Lecturer posts provide a salary but often do not come with the funding to support the costs of the research. This scheme was designed to help bridge this gap by providing Clinical Lecturers with access to modest research funds for up to two years. It gives them experience of preparing a research grant application and helps them establish their research portfolios by providing funding for research consumables.
So far we have supported 642 Clinical Lecturers through 28 rounds of funding, with grants totalling over £18 million. The 10th anniversary report (2018) and the latest annual report (2020) can be accessed in the 'Downloads' section.
In November 2020, the academy launched an exciting new programme called PILLAR (Promoting Innovation, Learning, Leadership And Resilience in the research community). This programmer offers support to our grant awardees. For more information please visit the main PILLAR page here.
The grants are intended as start-up funding and as such are not intended for applicants who have already obtained substantial funding through, for example, Clinician Scientist Fellowships, New Investigator Awards or large project grants.
All eligible applicants must:
1. Have a PhD or MD.
2. Hold a medical, dental or veterinary undergraduate degree and be registered with the General Medical Council, General Dental Council or Royal College of Veterinary Surgeons.
3. Hold a clinical contract at a UK institution.
If you are a clinician in human or dental medicine, you must also:
1. Be a research-active Clinical Lecturer
2. Hold an NTN or NTN(A)
3. Be within higher specialty training.
4. Have undertaken a substantial period of research equivalent to a PhD or research MD, if you have qualified abroad with an MD.
5. Note the following eligibility criteria relating to the timing of your CCT:
Senior Clinical Lecturers and Clinical Psychologists are not eligible for this scheme.
We are currently reviewing our eligibility criteria for dentistry applicants. We would encourage you to get in contact with the Office (firstname.lastname@example.org) if you would like to discuss your eligibility to the scheme.
If you are a clinician in veterinary medicine, you must be either:
1. A research-active Veterinary Specialist in Training (Resident/Senior Clinical Training Scholar) within an approved Specialist Training Programme with secured and protected research time throughout the proposed project.
2. A research-active Veterinary Clinician or Veterinary Pathologist with Veterinary Specialist Board qualification or eligibility and within the 3 year (probationary) period of your first University appointment and with secured and protected research time throughout the proposed project. If your position is that of a Senior Lecturer but are still within the three year probationary period then you are still eligible for this scheme.
We are currently reviewing our eligibility criteria for veterinary applicants. We would encourage you to get in contact with the Office (email@example.com) if you would like to discuss your eligibility to the scheme.
Please review the scheme FAQ document for full details on eligibility available for download in the 'Downloads' section..
Please contact the grants team if you have any other queries about the scheme at firstname.lastname@example.org
This scheme is targeted at those who are in the earlier years of their Clinical Lecturer appointment. You should not already have obtained substantial funding from other sources, for example a Clinician Scientist Fellowship, New Investigator Award or large project grant.
The maximum grant available is £30,000. This can be spread over one to two years to contribute towards directly incurred research costs, including (but not limited to) consumables, access charges, access to data sets, essential software and licences, and equipment.
Grants cannot be used to pay for your personal salary costs or to employ research assistants, PhD students or postdoctoral staff.
The Academy recognises the challenges clinicians face when managing a clinical and a research career with family and caring commitments. During the review process, prior career breaks will be taken into account when evaluating a candidate’s research output and progress. If you are successful, you will be able to apply for a no-cost extension to your grant to account for periods of absence or delays in your project during your award. For an example of the success such Starter Grant holders can achieve, please click here.
Successful applicants cannot reapply. Unsuccessful applicants are limited to one resubmission.
Starter Grant holders are eligible for the Academy's one-to-one mentoring scheme and are encouraged to contact the Office regarding this.
The current members of the selection panel are:
Professor Rosalind Smyth CBE FMedSci (Chair), UCL Great Ormond Street Institute of Child Health
Professor Ashley Blom FMedSci, University of Bristol
Professor Adnan Custovic FMedSci, Imperial College London
Professor Peter Ghazal OBE FMedSci, Cardiff University
Professor Deborah Lawlor CBE FMedSci, University of Bristol
Professor Ziad Mallat FMedSci, University of Cambridge
Professor Danny McAuley FMedSci, Queen's University Belfast
Professor Paul Moss OBE FMedSci, University of Birmingham
Professor Sir Munir Pirmohamed FMedSci, University of Liverpool
Professor Eleanor Riley CBE FRSE FMedSci, University of Edinburgh
Professor Sir Aziz Sheikh OBE FRSE FMedSci, University of Edinburgh
Applicants should not approach panel members to discuss their application. All queries should be directed to the secretariat (email@example.com).
All Starter Grant Holders are required to report via Researchfish annually by the end of March each year throughout their grant and for five years after the completion of their award. Click here for full reporting instructions.
A report of Starter Grant Holders' research outcomes submitted to us during our Researchfish submission window in 2020 is available for download in the 'Downloads' section.
You will also need to submit a Final Expenditure Report within three months of the end of your grant in addition to submitting Researchfish data. The final expenditure report blank template can be accessed by clicking on 'reporting' on your Flexi-Grant award page. If you require further assistance please do contact the Academy's grants team at firstname.lastname@example.org.
Caroline McCarthy, University of Liverpool, Multi-spectral phenotyping of the immune microenvironment in Oral Lichen Planus
Ryckie Wade, University of Leeds, Quantitative MRI of Skeletal Muscle For Assessing the Site and Severity of Ulnar Nerve Entrapment: A Pilot Study
Peter Hanlon, University of Glasgow, Enhancing routine healthcare data to compare frailty and multimorbidity in randomised controlled trials versus routine care
Joseph Ward, University College London, Using administrative data to estimate burden of chronic disease in children and young people in England
William Watson, University of Cambridge, Does increased lipid metabolism alter cardiac function in ischaemic cardiomyopathy?
Joshua Luis, University College London, Müller glial cell response during acute intraocular pressure elevation
Xilin Wu, Queen Mary University of London, Investigating the role of TMEM132E in the production of aldosterone, and whether it is required for membrane trafficking of nicotinic acetylcholine receptors in the adrenal.
Karyn Ayre, University of Edinburgh, An Implementation Science Approach to Complex Social Circumstances Among Antenatal Women with Moderate-Severe Mental Illness.
Donal Skelly, University of Oxford, Investigating the Immune Landscape of the Meninges in Alzheimer’s Disease: A Spatial Transcriptomics Pilot Study
Ana-Catarina Pinho-Gomes, University College London, Association between exposure to air pollution in utero and childhood health outcomes
Mark Ellul, University of Liverpool, Understanding disease mechanisms of postinfectious autoimmunity in herpes simplex virus encephalitis
Andreas Hadjinicolaou, University of Cambridge, Investigating the utility of the Cytosponge and molecular biomarkers to identify patients at risk of gastric cancer
Neil Graham, Imperial College London, The UK CTE Study - understanding the long-term outcomes of head impact exposure
Candice Downey, University of Leeds School of Medicine, A feasibility evaluation investigating the impact of emergency laparotomy and its complications on healthcare costs and patients’ quality of life
Sarah Prentice, London School of Hygiene and Tropical Medicine, Identifying transcriptomic signatures of BCG-induced protection against heterologous infections in infants
Lettie Rawlins, University of Exeter Medical School. A community approach to accelerate the discovery of the molecular basis of neurodevelopmental disorders in Pakistan
Lucy Plumb, University of Bristol, Refining and validating a clinical prediction score for childhood chronic kidney disease
Jennifer Lane, Queen Mary University of London, Improving surgical and device epidemiology in real world big data: leading an international collaboration
Jesmeen Maimaris, University College London, Genetic and immunological characterisation of novel JAK/STAT signalling pathway defects in primary immunodeficiency diseases
Zahra Raisi-Estabragh, Queen Mary University of London, The ONCOVER Study: Optimising cardiovascular risk stratification in people with cancer
Mohamed Mohamed, University College London, Risk assessment and long-term outcomes of acute coronary syndrome management strategy in cardio-oncology patients
Charikleia Papadopoulou, University of Cambridge, Understanding the molecular mechanisms behind ischaemic cardiomyopathy
Simon Abram, University of Oxford, Leveraging Routinely Collected Big Data to Benchmark and Improve Surgical Care Outcomes
Simon Bell, University of Sheffield, Understanding the role of Hexokinase 1 deficiency as a contributor to the cellular pathology of Alzheimer’s Disease.
Alison Berner, Queen Mary University of London, Genomic Origins Of Sex-bias in Colorectal Cancer Epidemiology (GOOSCCE)
Simon Biddie, University of Edinburgh, Uncovering functional host non-coding genetic variants associated with risk of severe COVID-19 using high-throughput screening
Matthew Clarke, Institute of Cancer Research, The classification and characterisation of high-grade gliomas in teenagers and young adults
Helen Devine, Newcastle University, Is there dysfunction at the neuromuscular junction in spinal bulbar muscular atrophy which can be a future target for therapeutic intervention in SBMA and other motor neuron diseases?
Sarah Dorrington, King's College London, Mental health and occupational outcomes of people accessing an early pregnancy unit (EPAU) in south London: an eLIXIR data linkage study
Alexander Fletcher, University of Glasgow, Non-invasive molecular imaging to measure fibroblast activation in right ventricular disease
Amanda Goodwin, University of Nottingham, Understanding how mesenchymal G protein signalling controls lung development and repair
Robert Hyde, University of Nottingham, The automated diagnosis of disease using machine vision: lameness in dairy cattle
Theresa Hydes, University of Liverpool, Patient preferences for the delivery of the non-alcoholic fatty liver disease clinical pathway: let’s move towards patient-centered care
Miriam Manook, University of Cambridge, Systems serology in transplantation: comprehensive profiling of HLA antibodies to stratify immunological risk
Chris Miles, St George's University of London, Utility of the high-lead ECG configuration during exercise stress testing in Brugada syndrome
Hannah Nieto, University of Birmingham, FNA-seq: Nanopore sequencing of fine needle aspirate samples to revolutionise the diagnosis and treatment of thyroid cancer
Karl Payne, University of Birmingham, COMBined Blood And Tissue prediction for immunotherapy response in recurrent/metastatic Head and Neck Squamous Cell Carcinoma (COMBAT HNSCC)
Laurence Pearmain, University of Manchester, Resolving monocyte-derived macrophage extracellular matrix crosstalk within the fibrotic niche for precision biomarker guided therapies in Idiopathic Pulmonary Fibrosis.
Adam Pennycuick, University College London, Parallelised Cancer Therapy based on Copy Number Targeting
Haseeb Rahman, King's College London, Improving diagnosis and outcomes of Coronary Microvascular Dysfunction by applying a network approach across the UK
Sayyid Raza, University of Manchester, Understanding the role of Neuron Navigator 3 in kidney fibrosis
Akshay Shah, University of Oxford, Inflammatory phenotypes, haemoglobin recovery and economic evaluation of treating anaemia in survivors of critical illness
Bo Sun, University of Oxford, Transcriptomic profiling of autoantibody-mediated neuronal perturbations in CASPR2-antibody encephalitis
Joshua Totty, Hull & York Medical School, First-in-man clinical trial investigating the effect of hair cycle modulation on wound healing.
Lucy Whitaker, University of Edinburgh, Improving understanding of endometriosis pain flares to support patients with self-management and prevention (EndoFLARE): a feasibility study
Yanushi Wijeyeratne, St George's University of London, Polygenic association study of risk and phenotype in SCN5A-E1784K families
Adam Al-Diwani, University of Oxford, Cervical lymph node aspirations: cellular and molecular phenotyping at an emerging neuro-immune nexus
Rubika Balendra, University College London, Investigating mechanisms of RNA dysregulation in C9orf72-associated motor neuron disease and frontotemporal dementia
Lucy Beishon, University of Leicester, Vascular mEchanismS in, dePression, dementiA, and deliRum: The VESPAR project
Floryne Buishand, Royal Veterinary College, University of London, Identification of novel druggable targets in canine insulinoma through single-cell transcriptomic analysis
Nicholas Cunniffe, University of Cambridge, Examining the long-term effects of the combination of metformin and clemastine on remyelination and neuroprotection; a follow-up study of the Cambridge Centre for Myelin Repair trial Two
Adam Dale, University of Southampton,
Characterising human CD4+ effector T cell responses following experimentally-induced colonisation with genetically-modified Neisseria lactamica expressing the meningococcal vaccine antigen, Neisseria adhesin A.
Kate Duhig, University of Manchester, Developing MRI sequences to Assess maternal cardiac and Placental function in women with HyperteNsion in prEgnancy (DAPHNE)
Laura Goodfellow, University of Liverpool,
Are yeasts the missing link between the vaginal bacteria and preterm birth?
Dermot Linden, Queen's University Belfast, Epstein-Barr Virus suppression in Chronic Obstructive Pulmonary Disease (EViSCO): A mechanistic study to evaluate the sputum transcriptome and microbiome in moderate-to-severe COPD
Johnathan Millar, University of Edinburgh,
Functional genomics and ARDS: in-silico and in-vitro gene editing to dissect genome wide associations in patients with Acute Respiratory Distress Syndrome
Camus Nimmo, Francis Crick Institute,
Targeted mutagenesis to identify resistance conferring mutations for new drugs for Mycobacterium tuberculosis
Emma Rose McGlone, Imperial College London, Hepatic glucagon sensitivity before and after bariatric surgery: use of a plasma biomarker to predict resolution of metabolic-associated liver disease
Michaela Reichmann, University of Southampton, Multidimensional transcriptomic analysis of tuberculosis granulomas to define pathophysiological mechanisms
Ola Rominiyi, University of Sheffield, High-grade glioma treatment design through mapping spatial differences in the DNA damage response of cancer stem cells
Neil Ryan, University of Bristol, MicrosatEllite Womb Surveillance (MEWS) study
Yazan Sulaiman Khaled, University of Leeds, Developing a novel theranostic nanoparticle for precision surgery in pancreatic cancer
Eugene Tang, Newcastle University,
The Impact of Cognitive Difficulties On Post-Stroke Recovery
Wendy Thompson, University of Manchester, Developing ways to evaluate process during the clinical trial of a dental antibiotic stewardship intervention
Oliver Todd, University of Leeds, Stratified hypertension management in later life: establishment of cohort linkage between ambulatory blood pressure measurements and routine health and social care data in Connected Bradford
Tabitha Turner-Stokes, Imperial College London, From human genetics to monocyte-specific disease mechanisms in systemic lupus erythematosus
Yize Wan, Queen Mary University of London, Acute illness as a driver of long-term disease and health inequality across socioeconomic and ethnic groups
Hannah Woodcock, University of Cambridge, Investigating lung epithelial progenitor cell fate in the developing human lung
Kathryn Allan, University of Glasgow, Investigating the impact of Coxiella burnetii infection on dairy cattle in Scotland.
Emily Bowen, University of Bristol, Investigating Shiga toxin-induced endothelial glycocalyx dysfunction as a potential therapeutic target in Haemolytic Uraemic Syndrome
Mitchell Chen, Imperial College London, Deep Learning and Radiomics-based Cardiovascular Disease Assessment on Ungated Contrast Enhanced Computed Tomography and its Integration in a Clinical Predictive Model for Patients with Non-Small Cell Lung Cancer
Radoslaw Debiec, University of Leicester, Bicuspid aorRtic vAlVe gEnetic research – tHoracic aortic 18F-fluoridE microcAlcification to monitoR aorTopathy (BRAVE-HEART substudy)
Lydia Finney, Imperial College London, Investigating the role of specialist pro-resolving mediators in viral exacerbations of chronic obstructive pulmonary disease
Daniel Fudulu, University of Bristol, Metabolomoics and clinical based predictive modles for acute kidney injury after coronary atery bypass grafting
Rebecca Gosling, University of Sheffield, Comprehensive modelling of myocardial ischaemic bur
Timothy Hardy, Newcastle University, Characterisation of somatic mutation analysis in cell free DNA of patients with Non Alcoholic Fatty Liver Disease
Jamilla Hussain, Hull & York Medical School, Health inequalities related to ethnicity and socio-economic position at the end-of-life
David Hutchings, University of Manchester, Why is lamin cardiomyopathy a perfect storm for arrhythmias?
Eleni Louka, University of Oxford, Investigating the mechanisms of relapse in Juvenile Myelomonocytic Leukaemia (JMML)
Imran Noorani, Francis Crick Institute, Defining the molecular impact of extrachromosomal oncogenes on cellular interactions in the glioblastoma microenvironment
Majd Protty, Cardiff Univeristy, Investigating the role of procoagulant enzymatically oxidized phospholipids in arterial thrombosis using in vivo models
Mahim Qureshi, University of Bristol, Composite primary endpoints for randomised controlled trials of invasive and surgical procedures
Rebecca Spencer, University of Leeds, Circulating placental extracellular vesicles as non-invasive placental biopsies and sources of diagnostic markers in fetal growth restriction
Tathyane Teshima, University College London, Identifying the cellular and genetic profile of salivary gland damage in Sjogren’s Syndrome with focus on how specific tissues influence disease at single-cell level
Ganesh Vigneswaran, University of Southampton, Machine learning to identify predictors of outcome and survival in the treatment of mUM (metastatic uveal melanoma) with M-PHP (melphalan percutaneous hepatic perfusion)
Akira Wiberg, University of Oxford, Developing a single cell atlas of the median nerve microenvironment in the carpal tunnel
Anam Anzark, Queen Mary University of London, Investigating a role of seizures in promoting progression of Glioblastoma Multiforme
Damiano Giuseppe Barone, University of Cambridge School of Clinical medicine, Minimally Invasive Spinal Cord Stimulation for chronic pain
Andrew Bell, University of Glasgow, The role of distinct populations of spinal excitatory interneurons in post-operative pain
Camilla Clark, St George's University Hospitals NHS, How we understand our emotions: Is alexithymia following traumatic brain injury a generalised failure of interoception?
Jonathan Evans, University of Exeter Medical School, Cross-Cultural Validation and Calibration of the PROMIS
Michael FitzPatrick, University of Oxford, Elucidating functional and spatial characteristics of CD8+ T cell populations in coeliac disease
Anne-Lise Goddings, University College London, The association between glycaemic control in young people with Type 1 diabetes mellitus and executive functioning in social contexts: a pilot study
Ankur Gupta-Wright, University College London, Improving diagnosis of presumptive TB in hospitalised patients in Malawi
Neil Halliday, University College London, Assessment of Treg function, CD28 costimulation and immune dysregulation in autoimmune liver diseases
James Howard, Imperial College London, Diastolic function assessment with cardiac magnetic resonance imaging and echocardiography: a scan-rescan study
Thomas Massey, Cardiff University, Using genetic modifiers to investigate the molecular mechanisms of repeat expansion in Huntington’s disease
James Masters, University of Oxford, Collecting Data on hip fracture surgery in sub-saharan africa (Hip fracturE surGery In sub-sahaRan Africa-HEGIRA)
Susanna Mills, Newcastle University, Mixed-methods study to generate evidence to inform weight management interventions in adult secure care mental health inpatient settings
Sophie Patterson, University of Lancaster, Expansion of Remote Contraceptive Services in England: Implications for Inequalities in Women’s Reproductive Health
Helen Payne, Imperial College London, Prevalence of cytomeglaovirus and Epstein Barr virus and associated immune-activation and inflammation in adolescents with perinatally-acquired HIV
Muhammad Rashid, Keele University School of Medicine, REadmissions, Adverse Complications and ouTcomes following Acute Myocardial Infarction (REACT-AMI) study
Jennifer Rayner, University of Oxford, Mapping complete energetic pathways in the human heart using magnetic resonance spectroscopy
Maria Rogdaki, King's College London, Determining the molecular mechanisms of psychosis and developing a cellular platform for novel drug discovery: From brain to cell and back again
Jakub Scaber, University of Oxford, Investigating selective vulnerability in C9orf72 positive amyotrophic lateral sclerosis using induced pluripotent stem cell derived motor and sensory neurons
Charlotte-Eve Short, Imperial College London, The immunological basis for increased Preterm Birth in HIV-1 infected pregnant women and the influence of different classes of antiretroviral therapy
Norman Shreeve, University of Cambridge School of Clinical Medicine, The fetal microglial response to glucocorticoid exposure in utero
Nicola Tempest, University of Liverpool, Preliminary study, characterising the region-specific abnormalities in the endometrium of women with recurrent implantation failure
Stephanie Worton, University of Manchester, Investigating novel treatments for maternal vascular dysfunction in the STOX1 model of pre-eclampsia; the missing link in the translational pathway
Amir Youshani, University of Manchester, Characterisation of senescence-associated secretory phenotype in glioblastoma
Tian Zhao, University of Cambridge, The effect of low-dose interleukin-2 on atherosclerotic plaque immune cells in patients undergoing carotid endarterectomy
The scheme is generously supported by the Wellcome Trust, Medical Research Council, British Heart Foundation, Arthritis Research UK, Royal College of Physicians and Diabetes UK.
The scheme is generously supported by the Wellcome Trust, Medical Research Council, British Heart Foundation, Versus Arthritis, Diabetes UK, Prostate Cancer UK, and the Association of Physicians of Great Britain & Ireland.
Tel: –View staff bio
Tel: 020 3141 3271View staff bio
Tel: -View staff bio